These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24882676)

  • 1. Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
    Wang XD; Wei W; Wang PF; Tang YT; Deng RC; Li B; Zhou SS; Zhang JW; Zhang L; Xiao ZP; Ouyang H; Zhu HL
    Bioorg Med Chem; 2014 Jul; 22(14):3620-8. PubMed ID: 24882676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
    Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
    Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
    Wang JX; Zhang YB; Liu ML; Wang B; Chai Y; Li SJ; Guo HY
    Eur J Med Chem; 2011 Jun; 46(6):2421-6. PubMed ID: 21481984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
    Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.
    Liu H; Huang J; Wang J; Wang M; Liu M; Wang B; Guo H; Lu Y
    Eur J Med Chem; 2014 Oct; 86():628-38. PubMed ID: 25218911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.
    Butler MM; Lamarr WA; Foster KA; Barnes MH; Skow DJ; Lyden PT; Kustigian LM; Zhi C; Brown NC; Wright GE; Bowlin TL
    Antimicrob Agents Chemother; 2007 Jan; 51(1):119-27. PubMed ID: 17074800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
    Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
    J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms.
    Xiao ZP; Wang XD; Wang PF; Zhou Y; Zhang JW; Zhang L; Zhou J; Zhou SS; Ouyang H; Lin XY; Mustapa M; Reyinbaike A; Zhu HL
    Eur J Med Chem; 2014 Jun; 80():92-100. PubMed ID: 24769347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent.
    Wang XD; Wei W; Wang PF; Yi LC; Shi WK; Xie YX; Wu LZ; Tang N; Zhu LS; Peng J; Liu C; Li XH; Tang S; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Aug; 23(15):4860-4865. PubMed ID: 26048027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.
    Zhang YB; Feng LS; You XF; Guo Q; Guo HY; Liu ML
    Arch Pharm (Weinheim); 2010 Mar; 343(3):143-51. PubMed ID: 20186866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and antibacterial evaluation of decarboxylated fluoroquinolones.
    Nguyen ST; Ding X; Butler MM; Tashjian TF; Peet NP; Bowlin TL
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5961-3. PubMed ID: 21865042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wang J; Liu M; Yi H; Sun L; You X; Guo H
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3377-80. PubMed ID: 21515052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tyrosinase, antioxidant, and antibacterial activities of novel 5-hydroxy-4-acetyl-2,3-dihydronaphtho[1,2-b]furans.
    Xia L; Idhayadhulla A; Lee YR; Wee YJ; Kim SH
    Eur J Med Chem; 2014 Oct; 86():605-12. PubMed ID: 25218909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD; Deng RC; Dong JJ; Peng ZY; Gao XM; Li ST; Lin WQ; Lu CL; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2013 Sep; 21(17):4914-22. PubMed ID: 23891164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and in vitro antibacterial activity of fluoroquinolone derivatives containing a chiral 3-(alkoxyimino)-2-(aminomethyl)azetidine moiety.
    Lv K; Sun Y; Sun L; Wei Z; Guo H; Wu J; Liu M
    ChemMedChem; 2012 Jul; 7(7):1230-6. PubMed ID: 22639240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics.
    Pokrovskaya V; Belakhov V; Hainrichson M; Yaron S; Baasov T
    J Med Chem; 2009 Apr; 52(8):2243-54. PubMed ID: 19301822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study.
    Abdel-Aziz AA; Asiri YA; Al-Agamy MH
    Eur J Med Chem; 2011 Nov; 46(11):5487-97. PubMed ID: 21982337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.